BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Submission of Matters to a Vote of Security Holders

BioLargo, Inc. (OTCMKTS:BLGO) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders

Story continues below

The Company held its 2018 annual stockholder meeting on May 23, 2018. The following matters were each submitted to a vote of stockholders through the solicitation of proxies or otherwise:

1.

A proposal to elect the following seven individuals to our Board of Directors: Dennis P. Calvert, Kenneth R. Code, Dennis E. Marshall, Joseph L. Provenzano, Kent C. Roberts II, John S. Runyan and Jack B. Strommen.

2.

Advisory approval of the Company’s executive compensation.

3.

A proposal to ratify the appointment of Haskell & White LLP as our independent public accounting firm for the 2018 fiscal year.

4.

A proposal to increase the authorized capital stock of the Company from 200,000,000 shares of common stock to 400,000,000 shares of common stock.

5.

A proposal to adopt the 2018 Equity Incentive Plan.

A quorum was present in person or by proxy. Each matter was approved. The voting results are as follows:

Proposal One

Votes For

Votes

Withheld

Broker

Non-Vote

Total Votes

(For +

Withheld)

Dennis P. Calvert

34,827,821

640,290

35,954,467

35,468,111

Kenneth R. Code

34,848,821

619,290

35,954,467

35,468,111

Dennis E. Marshall

35,086,896

381,215

35,954,467

35,468,111

Joseph L. Provenzano

34,737,572

730,539

35,954,467

35,468,111

Kent C. Roberts II

35,234,614

233,497

35,954,467

35,468,111

John S. Runyan

35,204,734

263,377

35,954,467

35,468,111

Jack B. Strommen

35,113,776

354,335

35,954,467

35,468,111

Proposals 2 – 5

Votes For

Votes

Against

Votes

Abstain

Broker Non-

Vote

Total votes

34,117,919

1,102,804

247,388

35,954,467

35,468,111

69,640,818

357,915

1,423,844

71,422,577

60,800,613

7,946,285

2,596,033

79,647

71,342,931

33,976,146

1,201,591

290,374

35,954,467

35,468,111

For the Advisory Approval of Executive Compensation, prior year votes are as follows:

Year

Votes For

Votes Against

Votes Abstain

Broker

Non-Vote

27,248,643

343,971

242,499

28,177,525

31,052,733

342,142

240,267

21,119,013

There were no director nominees other than as set forth above.


About BioLargo, Inc. (OTCMKTS:BLGO)

BioLargo, Inc. is a provider of platform technologies. The Company’s products are used to eliminate contaminants that threaten the water, health and quality of life. Its technology has commercial applications within several industries. The Company focuses on four areas: water treatment; industrial odor control applications; commercial, household and personal care products (CHAPP), and advanced wound care. Its AOS Filter combines iodine, water filter materials and electrolysis within a water filter device. It generates oxidation potential in order to oxidize and breakdown or otherwise eliminate, soluble organic contaminant, which are found in contaminated water. Its CupriDyne formula is used to deliver iodine within products. The Isan System is an automated iodine dosing system, which features controlled measuring, flow control, dosing and iodine extraction and removal technology, as well as an automatic tracking system that delivers iodine in calibrated doses.

An ad to help with our costs